Add like
Add dislike
Add to saved papers

[Increased expression of IL-9 in peripheral blood and liver tissues of patients with primary biliary cirrhosis].

Objective To investigate the expression and clinical significance of interleukin 9 (IL-9) in patients with primary biliary cirrhosis (PBC). Methods The study enrolled 80 PBC patients and 100 healthy subjects. Levels of serum IL-9, interferon γ (IFN-γ), IL-6, tumor necrosis factor α (TNF-α), IL-10 and IL-17 were determined by cytometric beads array (CBA); level of IL-9 mRNA in peripheral blood mononuclear cells (PBMCs) was detected by quantitative real-time PCR; the expression and location of IL-9 in liver tissues were detected by immunohistochemistry. Results Serum levels of IL-9, TNF-α, IL-6, IL-17, IFN-γ and IL-10 significantly increased in PBC patients in comparison with healthy controls, and a positively correlation between IL-9 and IgG was observed in PBC patients. In addition, the expression of IL-9 mRNA in PBC groups increased. Immunohistochemical results suggested that positive cells appeared in the PBC liver tissue, mainly in the portal area. Conclusion Expression of IL-9 remarkably increases in peripheral blood and liver tissues in patients with PBC.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app